Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rapid Dose Therapeutics Corp. plans to issue common shares to its non-management directors as a means of settling $150,000 in director fees, aiming to improve its financial position by reducing liabilities. This shares-for-debt transaction will not create a new control person and complies with Canadian regulatory exemptions.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.